A detailed history of Clark Capital Management Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 837,718 shares of BMY stock, worth $48.5 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
837,718
Previous 7,678 10810.63%
Holding current value
$48.5 Million
Previous $318,000 13532.39%
% of portfolio
0.3%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $32.9 Million - $43 Million
830,040 Added 10810.63%
837,718 $43.4 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $4,508 - $5,934
-112 Reduced 1.44%
7,678 $318,000
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $265,569 - $301,104
-5,535 Reduced 41.54%
7,790 $422,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $77,180 - $92,097
-1,592 Reduced 10.67%
13,325 $683,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $87,934 - $98,324
-1,519 Reduced 9.24%
14,917 $865,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $257,197 - $285,577
-4,037 Reduced 19.72%
16,436 $1.05 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $13,141 - $14,906
200 Added 0.99%
20,473 $1.42 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $247,075 - $292,572
-3,608 Reduced 15.11%
20,273 $1.46 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $44,821 - $26.5 Million
-344,784 Reduced 93.52%
23,881 $1.7 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $1.67 Million - $1.84 Million
23,050 Added 6.67%
368,665 $28.4 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $20 Million - $24 Million
325,193 Added 1592.37%
345,615 $25.2 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $23,865 - $27,821
-445 Reduced 2.13%
20,422 $1.27 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $46,034 - $53,923
-778 Reduced 3.59%
20,867 $1.24 Million
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $43.6 Million - $47.4 Million
-703,603 Reduced 97.02%
21,645 $1.45 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $2.41 Million - $2.71 Million
-40,643 Reduced 5.31%
725,248 $45.8 Million
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $1.74 Million - $1.97 Million
-30,087 Reduced 3.78%
765,891 $47.5 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $10.2 Million - $11.3 Million
-178,333 Reduced 18.3%
795,978 $48 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $2.31 Million - $2.7 Million
-42,136 Reduced 4.15%
974,311 $57.3 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $11.4 Million - $16.6 Million
-246,452 Reduced 19.51%
1,016,447 $56.7 Million
Q4 2019

Jan 27, 2020

BUY
$49.21 - $64.19 $22.1 Million - $28.8 Million
448,807 Added 55.13%
1,262,899 $81.1 Million
Q3 2019

Nov 06, 2019

SELL
$42.77 - $50.71 $15.2 Million - $18 Million
-355,544 Reduced 30.4%
814,092 $41.3 Million
Q2 2019

Jul 12, 2019

SELL
$44.62 - $49.34 $291,725 - $322,584
-6,538 Reduced 0.56%
1,169,636 $53 Million
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $31.7 Million - $37.8 Million
703,116 Added 148.63%
1,176,174 $56.1 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $957,207 - $1.24 Million
19,631 Added 4.33%
473,058 $24.6 Million
Q3 2018

May 08, 2019

SELL
$55.19 - $62.25 $10,154 - $11,454
-184 Reduced 0.04%
453,427 $28.1 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $23.6 Million - $26.6 Million
426,918 Added 1599.36%
453,611 $28.2 Million
Q2 2018

May 08, 2019

SELL
$50.53 - $62.98 $1,364 - $1,700
-27 Reduced 0.1%
26,693 $1.48 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $100,453 - $125,204
-1,988 Reduced 6.92%
26,720 $1.48 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $222,303 - $255,915
-3,710 Reduced 11.44%
28,708 $1.82 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $553,665 - $603,637
9,237 Added 39.85%
32,418 $1.99 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $1.28 Million - $1.48 Million
23,181
23,181 $1.48 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.